ǰÑÔ
Àà·çʪÐÔÊàŦÑ×(rheumatoid arthritis,RA)ÊÇÒÔÂýÐÔ¶àÊàŦÑ×֢ΪÖ÷ÒªÌåÏÖµÄÂýÐÔÈ«ÉíÐÔ×ÔÉíÃâÒßÐÔ¼²²¡¡£Ö÷ÒªÀÛ¼°¹ÇÊàŦºÍÊàŦǻ£¬ÒÔÊàŦǻ»¬Ä¤Ñ×Ö¢¡¢ÉøÒº¡¢Ï¸°ûÔöÖ³¡¢ÈâÑ¿Ö×Ðγɡ¢Èí¹Ç¼°¹Ç×éÖ¯ÆÆËðΪÆäÖ÷ÒªµÄ²¡ÀíÑ§ÌØÕ÷¡£¶àÇÖռСÊàŦ£¬ÈçÊÖ¡¢×ã¼°ÍóÊàŦµÈ£¬³£Îª¶Ô³ÆÐÔ£¬³ÊÂýÐÔ¾ÓÉ¡£ÑªÇåÖпɲ鵽×ÔÉí¿¹ÌåѪÇåÀà·çʪÒò×Ó¡£·¢²¡ÄêËê¶àÔÚ20~40ËꡣŮÐÔ¶àÓÚÄÐÐÔ¡£
RAµÄ²¡ÒòºÍ·¢²¡»úÖÆÉÐδÍêÈ«ÇåÎú£¬Óë·¢²¡ÓйصÄÒòËØÓУº¢Ù×ÔÉíÃâÒß¹¦Ð§ÔÓÂÒ£º×ÔÉíÃâÒßϵͳµ÷Àí¹¦Ð§ÔÓÂÒËùÖµÄÑ×Ö¢·´Ó¦ÐÔ¼²²¡¡£¢ÚÒÅ´«£ºÓëÀà·çʪÊàŦÑ×·¢²¡Ïà¹ØµÄÒ׸лùÒò°üÀ¨HLADR¡¢PADI4ºÍPTPN22µÈ¡£±¾²¡»¼ÕßHLA-DRwu¿¹Ô¼ì³öÂÊÏÔ×ÅÉý¸ß£¬ÌáÐÑ·¢²¡ÓëÒÅ´«Óйء£¢ÛѬȾ£ºÓëÀà·çʪÊàŦÑ×·¢²¡Ïà¹ØµÄ²¡ÔÌå°üÀ¨EB²¡¶¾¡¢Ï¸Ð¡²¡¶¾B19¡¢Á÷¸Ð²¡¶¾¼°½áºË·ÖÖ¦¸Ë¾úµÈѬȾ¡£
RAµÄ¶¯ÎïÄ£×ÓÓÐÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓºÍת»ùÒò¶¯ÎïÄ£×Ó2À࣬ÒÔÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓʹÓÃ×îÆÕ±é¡£
ÖÁ½ñΪֹÔÚRAÑо¿ÉÏ£¬ÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓÓ¦ÓÃ×î¹ã¡£Ëü²»µ«¿ÉÓÃÄö³ÝÀදÎïÖÆ×÷£¬Òà¿ÉÓÃÍá¢È®ºÍºï¡£ÓÕ·¢¼ÁµÄÖÖÀàÒàÐí¶à£¬ÆäÖÐAAÄ£×Ó¡¢CIAÄ£×ÓºÍOIAÄ£×Ó±¨µÀ½Ï¶à¡£µ«ÕâЩÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓÔÚ²¡Àí¸Ä±äºÍÃâÒßϵͳµ÷ÀíÔÓÂÒÉÏÓëÈ˵ÄÁÙ´²ÌåÏÖÉÐÓÐÒ»¶¨µÄ²î±ð£¬ÈçûÓп¹ºË¿¹Ì壬ҲûÓÐRAµÄƤϽá½Ú¡¢½¬Ä¤Ñס¢Ñª¹ÜÑ×µÈÌåÏÖ£¬RA¶¯ÎïÄ£×ÓÖ»ÊÇÔÚÒ»¶¨Ìõ¼þÏ£¬×ÅÖØÓÚijһ¸ö»òij¼¸¸öÒòËØ¶ø½¨ÉèÆðÀ´µÄ£¬²»¿ÉÍêÈ«·´Ó¦RAµÄËùÓÐÌØµã¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
Ö×Áö»µËÀÒò×Óα(tumor necrosis factor-α, TNF-α)Ö÷ÒªÊÇÓɻµÄ¾ÞÊÉϸ°ûÉøÍ¸£¬»î»¯µÄTϸ°û¡¢NKϸ°ûÒÔ¼°·Ê´óϸ°ûÒ²ÓÐÉÙÁ¿ÉøÍ¸¡£¶øTNF-aÌØÒìÐÔĤÊÜÌåÔò±£´æÓÚÏÕЩËùÓÐÖÖÖÖϸ°ûÀàÐÍ¡£TNF×î³õ·¢Ã÷ÓëÖ×ÁöÓйأ¬ÏÖÒÑÇåÎúËüÊÇÕý³£ºÍÂýÐÔÑ×Ö¢µÄÃâÒßµ÷ÀíÎï¡£
ÒѾ·¢Ã÷ÔÚRA»¼ÕßÊàŦҺÖÐTNF-α¡¢IL-1ºÍIL-6º¬Á¿Éý¸ß£¬Åú×¢RAµÄ·¢²¡»úÖÆÖÐÓëTNF-αÓйء£½«ÈËTNF-α»ùÒòÔÚСÊó±í´ï¿É²¿·ÖÄ£ÄâRAµÄÁÙ´²ÌåÏÖ¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
º¬ÓÐÍêÕûÈËTNF-α»ùÒòºÍ5'¶Ë0.6kbÐòÁÐÓëÈËβÇòÂѰ׻ùÒòµÄ3'δ·ÒëÇøºÍ¾ÛÏÙÜÕËữλµãÖØ×飬ÐγÉTNF-globinÖØ×éDNAƬ¶Ï¡£ÕâÖÖÐÞÊÎÌṩÁËÐëÒªµÄ¾ÛÏÙÜÕËữÐźţ¬²¢²»×ÌÈÅÒ°ÉúÐÍÈËTNFµÄÕý³£·Òë¡£½«´ËÖØ×éDNAƬ¶ÏÏÔ΢עÉäµ½(CBA×C57B1/6)F1СÊóÊܾ«ÂÑÖУ¬ÔÚÊ×½¨ÊóÖоɸѡ£¬»ñµÃRAת»ùÒòСÊóÄ£×Ó¡£
¡¾Ä£×ÓÌØµã¡¿£º
¸ÃÄ£×ÓÒÔõ×ÊàŦÖ×ÕÍ¡¢Ô˶¯ÕϰΪÖ÷ÒªÁÙ´²ÌåÏÖ£¬²¢ÇÒ100£¥ÒÅ´«¸øÏÂÒ»´ú¡£3~4ÖÜÁä×îÏÈÏÔ×Å·¢²¡£¬õ×ÊàŦÖ×ÕÍ£¬´Ëʱ¿ÉÊӲ쵽»¬Ä¤ÔöÉú¡£5ÖÜÁäǰõ×ÊàŦÖ×ÕÍÏÔ×Å£¬ÏÔ΢¾µÏ»¬Ä¤ÏÔ×ÅÔöÉúºÍÑ×Ö¢¡£9~10ÖÜÁäʱ֫ÌåÔ˶¯ÕϰÉú³¤µ½ºóÖ«ÍêÈ«ËðʧÔ˶¯¡£ÌåÖØ¼õÇáÊÇÕâЩСÊóµÄÅäºÏÌØÕ÷¡£
×éÖ¯²¡Àíѧ¼ì²é£¬²¡±ä³ÊË«²à¶Ô³Æ¶àÊàŦÑ×£¬´Ó3ÖÜÁäÆð»¬Ä¤ÔöÉú£¬»¬Òº¼ä϶¶àÐκ˺ÍÁܰÍϸ°û½þÈóÔÚ²î±ðÉú³¤½×¶ÎµÄËùÓÐÊàŦÖкÜÏÔ×Å¡£±ðµÄ£¬Ñª¹ÜôèÐγɣ¬ÊàŦÈí¹ÇÆÆËð£¬ÏËά×éÖ¯ÌìÉú£¬ÕâÐ©ÌØÕ÷¾ùÓëÈËRAºÜÊÇÀàËÆ¡£
¿ÉÊÇ£¬ÔÚ´ËÄ£×ÓСÊó¼²²¡µÄ¸÷¸ö½×¶Î¾ùδÔÚѪÇåÖмì³öÀà·çʪÒò×Ó£¬Ò²Î´·¢Ã÷·çʪ½á½Ú£¬ÕâÊÇÓëÈËRAµÄ²î±ðÖ®´¦¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
TNFÄ£×Ó¿ÉÓÃÓÚÀà·çʪÐÔÊàŦÑ׵ķ¢²¡»úÖÆ¡¢×ÔÉíÃâÒß²¡ÀíµÈµÄÑо¿ÒÔ¼°Àà·çʪÐÔÊàŦÑ×Ò©ÎïµÄҩЧѧÑо¿¡£
²Î¿¼ÎÄÏ×£º
1.ÁõÇí£¬Íõ³¿Ñþ£¬·½½£ÇÇ£®Àà·çʪÐÔÊàŦÑ×¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®Ò½Ñ§×ÛÊö£¬2006, 12(5):313-316
2.Áֺ죬ºØÓÀ»³£¬ÀèÑ࣬µÈ£®¢òÐͽºÔÂѰ×Ó븥ÊÏÍêÈ«×ô¼Á´óÊóÊàŦÑ×Ä£×ӵĽ¨ÉèºÍ½ÏÁ¿£®ÖйúʵÑ鶯Îïѧ±¨£¬1999,7(1):1-6
3.Keffer J, Probert L, Cazlaris H, et al. Transgenic mic expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J, 1991, 10 (13):4025- 4031
4.McKenzie SE, Taylor SM, Malladi P, et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol, 1999, 162(7):4311-4318
5.Wooley PH. Animal models of rheumatoid arthritis. Curr Opin Rheumalol, 1991, 3 (3):407-420
6.Wollheim FA,Telhag H,Henricsson A,el al. Prevention of joint destruction in antigen induced arthritis. Clin lmmunol Immunopathol, 1994,70 (1):19-21
7.Hu Y, Cheng W, Cai W, el al. Advances in research on animal models of rheumatoid arthritis. Clin Rheumatol, 2013,32(2): 161-165